Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naive Participants With Castration-Resistant Prostate Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
This is a double-blind, placebo-controlled, multiregional Phase1/2 study to characterize the pharmacokinetic and pharmacodynamic responses to orteronel when administered concomitantly with prednisone in Chemotherapy-Naive Participants With Castration-Resistant Prostate Cancer
Epistemonikos ID: dd87f8dcab5a52f925bd93d6dbe83c8517b3fec0
First added on: May 11, 2024